The global Extracorporeal Membrane Oxygenation Machine Market is witnessing steady growth as hospitals expand advanced life-support capabilities for patients experiencing severe cardiac and respiratory failure. According to a recent study by SNS Insider, the global Extracorporeal Membrane Oxygenation Machine Market size valued at USD 0.49 billion in 2025, is anticipated to grow to USD 0.79 billion by 2035, registering a CAGR of 4.91% over the 2026–2035 forecast period. Increasing clinical acceptance of extracorporeal life support, continuous technological improvements, and broader hospital investment in critical care infrastructure are supporting long-term market expansion.
Increasingly, medical professionals have started using ECMO machines in emergencies, cardiology, and ICU settings in order to enhance patient outcomes by providing short-term assistance in breathing and pumping blood. With the increasing development of critical care facilities by medical organizations, manufacturers have come up with improved monitoring tools, portability options, and intelligent circuit management for ECMO devices.
To Get Detailed Insights on the Extracorporeal Membrane Oxygenation Machine Market – Request a Sample Report
Advanced Critical Care Programs Expand ECMO Adoption
There is an ever-increasing demand for ECMO owing to the increase in incidence of cardiovascular illnesses, respiratory problems, and complicated surgeries. The current-day ECMO units come with increased portability, patient monitoring, and added safety features, thus allowing treatments to be carried out in places other than traditional intensive care settings.
The rise in the number of ECPRs, along with the emergence of portable ECMOs and circuit management using artificial intelligence, has opened up new avenues for clinicians to provide prompt interventions and efficient patient management.
Key Market Findings Highlight Expanding Clinical Applications
Adult patients accounted for approximately 59.13% of market revenue in 2025, supported by the high prevalence of cardiogenic shock, heart failure, and acute respiratory distress syndrome requiring extracorporeal support. Meanwhile, the pediatric segment is projected to record the fastest expansion, advancing at a CAGR of 8.20% through 2035 as neonatal care capabilities continue improving.
Cardiac applications represented the leading clinical use, contributing approximately 49.38% of total revenue in 2025 owing to widespread utilization in cardiogenic shock management and complex cardiac procedures. Emergency extracorporeal cardiopulmonary resuscitation (ECPR) is forecast to become the fastest-growing application with a 7.85% CAGR, supported by growing clinical evidence and broader implementation across emergency departments.
Among product categories, Venovenous ECMO maintained the largest market share because of its extensive use in respiratory support, while Venoarterial ECMO is expected to experience stronger growth as demand increases for combined cardiac and pulmonary assistance. Hospitals remained the dominant end-user segment, with academic medical centers continuing to generate the highest procedural volumes worldwide.
Innovation Focuses on Mobility, Automation, and Better Patient Outcomes
The medical equipment manufacturers are currently focusing on designing ECMO devices that are smaller, smarter, and user-friendly. The portable ECMO devices that help to facilitate transport of patients from one hospital to another have helped to increase access to this life saving technology.
The artificial intelligence-based monitoring system has become available to assist the healthcare professionals in making adjustments in terms of flow in the pumps, gas exchange, and anticoagulation management. Along with the advances in oxygenator technology and circuitry, these technologies are anticipated to bring about increased efficiency while decreasing reliance on skilled labor.
Regional Markets Continue to Strengthen
The North America region accounted for the largest share of the Extracorporeal Membrane Oxygenation Machine Market share of the global market in 2025, contributing around 44.17% towards the total global revenue. In 2025, the United States accounted for nearly 86.4% of the North America market and was valued at around USD 0.145 billion and is forecasted to grow to USD 0.212 billion in 2035 at a CAGR of 4.91%.
The Asia Pacific region is expected to lead in growth with an anticipated CAGR of 5.79% over the forecast period, owing to continuous investments in tertiary hospitals, increasing availability of ECMO training programs, and growing health care spending. Japan contributed around 34.7% of the total revenue of Asia Pacific in 2025. Germany was responsible for 26.8% share of the Europe market and Saudi Arabia accounted for 28.3% of the Middle East & Africa revenue.
Leading Companies Strengthen Product Development
Competition within the Extracorporeal Membrane Oxygenation Machine Market continues to intensify as manufacturers invest in next-generation life-support technologies, portable platforms, digital monitoring capabilities, and strategic collaborations with healthcare institutions.
Major companies operating in the global market include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG (Fresenius Medical Care), Eurosets S.r.l., MicroPort Scientific Corporation, OriGen Biomedical, Nipro Corporation, ALung Technologies Inc., Thoratec Corporation (Abbott), MAQUET Holding B.V. & Co. KG, Fresenius Medical Care AG, Hemovent GmbH, Novalung GmbH (Xenios), MC3 Cardiopulmonary, SciMed Life Systems, BioLung, Surmodics Inc., and Breethe Inc.
An SNS Insider analyst Parry Kardani commented, "The ECMO market is entering a new phase of clinical adoption as portable technologies, AI-assisted monitoring, and expanding emergency care protocols improve accessibility and treatment efficiency. Companies delivering reliable, intelligent, and patient-centric extracorporeal support systems will be well positioned to benefit from the growing demand across global critical care settings.
About the Author
Get in touch
